Latest News

STAT Plus: Industry groups push back against ‘troubling’ FDA crackdown on genetic tests used to predict response to drugs

In recent weeks, the genetic testing world has been rattled by the Food and Drug Administration’s efforts to quietly pressure a number of companies to stop reporting results to patients about how their genes may interact with specific drugs. Now, increasingly, the industry is pushing back.

On Wednesday, a trade group that represents clinical laboratories sent a sharply worded letter to the agency calling its enforcement actions “troubling” and “inappropriate.” The letter, from the American Clinical Laboratory Association, warned that the agency’s actions could stifle the growth of a burgeoning industry and make it harder for patients to get the right types and doses of their medications.

Continue to STAT Plus to read the full story…

Source link

Related posts

Euler systems with local conditions


COVID-19: Mental Illness the 'Inevitable' Next Pandemic?


Robots to Greet, Triage Incoming Coronavirus Patients


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World